TEVJF

Teva Pharmaceutical Industries Limited

USD

Set alert

Price alert · TEVJF

All alert types
38.98 USD 0.00 0.00%
As of Sep 18, 2026
32.89 Day range 38.98
14.32 52-week range 39.70
YTD
+36.25%
1 year
+118.99%
Open
32.89
Prev close
38.98
Mkt cap
45.42B
Vol
5
Avg vol
433.76K
EPS
2.86
P/E
13.63
More statistics
Low
32.89
High
38.98
Earnings
Nov 11, 2026

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for TEVJF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

0.91 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 23.3×
FY 2016: 729×FY 2017: -0.9×FY 2018: -7.6×FY 2019: -9.7×FY 2020: -2.4×FY 2021: 22.8×FY 2022: -4.1×FY 2023: -17.2×FY 2024: -12.8×FY 2025: 23.3×
FY 2016 5y median -4.1× FY 2025
P/S 1.9×
FY 2016: 2.2×FY 2017: 0.7×FY 2018: 0.9×FY 2019: 0.6×FY 2020: 0.6×FY 2021: 0.6×FY 2022: 0.7×FY 2023: 0.6×FY 2024: 1.3×FY 2025: 1.9×
FY 2016 5y median 0.7× FY 2025
P/B 4.1×
FY 2016: 1.5×FY 2017: 0.9×FY 2018: 1.1×FY 2019: 0.7×FY 2020: 1.0×FY 2021: 0.9×FY 2022: 1.3×FY 2023: 1.3×FY 2024: 3.9×FY 2025: 4.1×
FY 2016 5y median 1.3× FY 2025
P/FCF 12.8×
FY 2016: 11.3×FY 2017: 5.8×FY 2018: 9.1×FY 2019: 22.8×FY 2020: 16.1×FY 2021: 40.4×FY 2022: 9.5×FY 2023: 11.5×FY 2024: 27.9×FY 2025: 12.8×
FY 2016 5y median 12.8× FY 2025
EV/EBITDA 8.7×
FY 2016: 28.9×FY 2017: -2.9×FY 2018: 262×FY 2019: 27.3×FY 2020: -14.7×FY 2021: 10.1×FY 2022: -37.0×FY 2023: 6.1×FY 2024: 45.9×FY 2025: 8.7×
FY 2016 5y median 8.7× FY 2025
EV/Sales 2.7×
FY 2016: 3.8×FY 2017: 2.1×FY 2018: 2.3×FY 2019: 2.1×FY 2020: 2.1×FY 2021: 1.9×FY 2022: 1.9×FY 2023: 1.7×FY 2024: 2.2×FY 2025: 2.7×
FY 2016 5y median 1.9× FY 2025
FCF Yield 7.8%
FY 2016: 8.9%FY 2017: 17.3%FY 2018: 11.0%FY 2019: 4.4%FY 2020: 6.2%FY 2021: 2.5%FY 2022: 10.5%FY 2023: 8.7%FY 2024: 3.6%FY 2025: 7.8%
FY 2016 5y median 7.8% FY 2025

Profitability

Gross Margin 51.8%
FY 2016: 54.1%FY 2017: 48.4%FY 2018: 44.0%FY 2019: 44.6%FY 2020: 46.4%FY 2021: 47.8%FY 2022: 46.7%FY 2023: 48.3%FY 2024: 48.7%FY 2025: 51.8%
FY 2016 5y median 48.3% FY 2025
Operating Margin 12.5%
FY 2016: 9.8%FY 2017: -78.1%FY 2018: -8.7%FY 2019: 16.6%FY 2020: 18.3%FY 2021: 10.8%FY 2022: 17.1%FY 2023: 2.7%FY 2024: -1.8%FY 2025: 12.5%
FY 2016 5y median 10.8% FY 2025
Net Margin 8.9%
FY 2016: 1.5%FY 2017: -72.7%FY 2018: -11.4%FY 2019: -5.8%FY 2020: -24.6%FY 2021: 2.6%FY 2022: -16.4%FY 2023: -3.5%FY 2024: -9.9%FY 2025: 8.9%
FY 2016 5y median -3.5% FY 2025
ROE 19.3%
FY 2016: 1.0%FY 2017: -93.7%FY 2018: -14.6%FY 2019: -7.1%FY 2020: -40.9%FY 2021: 4.1%FY 2022: -31.3%FY 2023: -7.4%FY 2024: -30.5%FY 2025: 19.3%
FY 2016 5y median -7.4% FY 2025
ROIC 7.4%
FY 2016: 1.0%FY 2017: -27.8%FY 2018: -3.1%FY 2019: 4.7%FY 2020: 7.2%FY 2021: 3.1%FY 2022: 5.8%FY 2023: 1.3%FY 2024: -1.1%FY 2025: 7.4%
FY 2016 5y median 3.1% FY 2025
ROA 3.7%
FY 2016: 0.4%FY 2017: -23.0%FY 2018: -3.5%FY 2019: -1.7%FY 2020: -8.1%FY 2021: 0.9%FY 2022: -5.6%FY 2023: -1.3%FY 2024: -4.2%FY 2025: 3.7%
FY 2016 5y median -1.3% FY 2025

Growth (YoY)

Revenue 4.3%
FY 2016: 11.5%FY 2017: 2.2%FY 2018: -15.8%FY 2019: -10.4%FY 2020: -1.4%FY 2021: -4.7%FY 2022: -6.0%FY 2023: 6.2%FY 2024: 4.4%FY 2025: 4.3%
FY 2016 FY 2025
Operating Income 811.9%
FY 2016: -35.7%FY 2017: -911.7%FY 2018: 90.6%FY 2019: 270.9%FY 2020: 9.2%FY 2021: -43.8%FY 2022: 49.1%FY 2023: -83.1%FY 2024: -170.0%FY 2025: 811.9%
FY 2016 FY 2025
EPS (diluted) 183.4%
FY 2016: -96.2%FY 2017: -22971.4%FY 2018: 86.8%FY 2019: 57.3%FY 2020: -330.0%FY 2021: 109.8%FY 2022: -676.3%FY 2023: 77.2%FY 2024: -190.0%FY 2025: 183.4%
FY 2016 FY 2025
Free Cash Flow 241.4%
FY 2016: -9.4%FY 2017: -39.1%FY 2018: -31.8%FY 2019: -76.7%FY 2020: 52.3%FY 2021: -63.0%FY 2022: 341.5%FY 2023: -19.2%FY 2024: -11.0%FY 2025: 241.4%
FY 2016 FY 2025

Financial Health

Current Ratio 1.0×
FY 2016: 0.9×FY 2017: 0.9×FY 2018: 1.0×FY 2019: 1.0×FY 2020: 1.0×FY 2021: 1.1×FY 2022: 1.1×FY 2023: 1.0×FY 2024: 1.0×FY 2025: 1.0×
FY 2016 5y median 1.0× FY 2025
Quick Ratio 0.8×
FY 2016: 0.6×FY 2017: 0.6×FY 2018: 0.6×FY 2019: 0.7×FY 2020: 0.7×FY 2021: 0.8×FY 2022: 0.7×FY 2023: 0.7×FY 2024: 0.7×FY 2025: 0.8×
FY 2016 5y median 0.7× FY 2025
Debt / Equity 2.2×
FY 2016: 1.1×FY 2017: 1.9×FY 2018: 2.0×FY 2019: 2.0×FY 2020: 2.6×FY 2021: 2.3×FY 2022: 2.8×FY 2023: 2.7×FY 2024: 3.4×FY 2025: 2.2×
FY 2016 5y median 2.7× FY 2025
Net Debt / EBITDA 2.5×
FY 2016: 12.0×FY 2017: -2.0×FY 2018: 163×FY 2019: 19.8×FY 2020: -10.3×FY 2021: 7.0×FY 2022: -24.2×FY 2023: 3.9×FY 2024: 19.0×FY 2025: 2.5×
FY 2016 5y median 3.9× FY 2025
Interest Coverage 2.1×
FY 2016: 4.4×FY 2017: -19.5×FY 2018: -1.9×FY 2019: 3.4×FY 2020: 3.8×FY 2021: 1.6×FY 2022: 2.7×FY 2023: 0.4×FY 2024: -0.3×FY 2025: 2.1×
FY 2016 5y median 1.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 3.2%FY 2017: 7.6%FY 2018: 0.1%FY 2019: 0.6%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 473.6%FY 2017: -7.1%FY 2018: -1.0%FY 2019: -5.4%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31